問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-01-01 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites2Sites
Recruiting2Sites
2025-06-02 - 2027-12-31
2018-08-01 - 2025-12-31
Participate Sites10Sites
Recruiting10Sites
2023-12-01 - 2029-04-30
Participate Sites9Sites
Recruiting9Sites
2022-01-01 - 2024-07-31
Locally Advanced or Metastatic Unresectable Urothelial Cancer
Sacituzumab Govitecan
Participate Sites11Sites
Recruiting11Sites
2022-06-15 - 2029-09-30
Participate Sites4Sites
Recruiting4Sites
2022-02-04 - 2025-06-13
Participate Sites3Sites
Recruiting3Sites
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2024-07-17 - 2027-07-30
Participate Sites1Sites
Recruiting1Sites
2024-03-01 - 2027-05-31
全部
